Antimalarial drug synergism and antagonism: Mechanistic and clinical significance

被引:137
作者
Bell, A [1 ]
机构
[1] Univ Dublin Trinity Coll, Moyne Inst Prevent Med, Dept Microbiol, Dublin 2, Ireland
关键词
malaria; Plasmodium; drug interactions;
D O I
10.1016/j.femsle.2005.09.035
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Interactions between antimicrobial agents provide clues as to their mechanisms of action and influence the combinations chosen for therapy of infectious diseases. In the treatment of malaria, combinations of drugs, in many cases acting synergistically, are increasingly important in view of the frequency of resistance to single agents. The study of antimalarial drug interactions is therefore of great significance to both treatment and research. It is therefore worrying that the analysis of drug-interaction data is often inadequate, leading in some cases to dubious conclusions about synergism or antagonism. Furthermore, making mechanistic deductions from drug-interaction data is not straightforward and of the many reported instances of antimalarial synergism or antagonism, few have been fully explained biochemically. This review discusses recent findings on antimalarial drug interactions and some pitfalls in their analysis and interpretation. The conclusions are likely to have relevance to other antimicrobial agents. (c) 2005 Federation of European Microbiological Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:171 / 184
页数:14
相关论文
共 81 条
[1]  
Akompong T, 2000, ANTIMICROB AGENTS CH, V44, P3107, DOI 10.1128/AAC.44.1.88-96.2000
[2]   Synergism of benflumetol and artemether in Plasmodium falciparum [J].
Alin, MH ;
Björkman, A ;
Wernsdorfer, WH .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1999, 61 (03) :439-445
[3]   Synergistic in vitro antimalarial activity of plant extracts used as traditional herbal remedies in Mali [J].
Azas, N ;
Laurencin, N ;
Delmas, F ;
Di Giorgio, C ;
Gasquet, M ;
Laget, M ;
Timon-David, P .
PARASITOLOGY RESEARCH, 2002, 88 (02) :165-171
[4]   PLASMODIUM-FALCIPARUM - DIFFERENTIAL SENSITIVITY INVITRO TO E-64 (CYSTEINE PROTEASE INHIBITOR) AND PEPSTATIN-A (ASPARTYL PROTEASE INHIBITOR) [J].
BAILLY, E ;
JAMBOU, R ;
SAVEL, J ;
JAUREGUIBERRY, G .
JOURNAL OF PROTOZOOLOGY, 1992, 39 (05) :593-599
[5]   Potentiation of artemisinin activity against chloroquine-resistant Plasmodium falciparum strains by using heme models [J].
Benoit-Vical, F ;
Robert, A ;
Meunier, B .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (10) :2555-2558
[6]   In vitro and in vivo potentiation of artemisinin and synthetic endoperoxide antimalarial drugs by metalloporphyrins [J].
Benoit-Vical, F ;
Robert, A ;
Meunier, B .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (10) :2836-2841
[7]   METHOD FOR TESTING FOR SYNERGY WITH ANY NUMBER OF AGENTS [J].
BERENBAUM, MC .
JOURNAL OF INFECTIOUS DISEASES, 1978, 137 (02) :122-130
[8]  
BERRY C, 1999, PROTEASES INFECT AGE, P165
[9]   Heme binding contributes to antimalarial activity of bis-quaternary ammoniums [J].
Biagini, GA ;
Richier, E ;
Bray, PG ;
Calas, M ;
Vial, H ;
Ward, SA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (08) :2584-2589
[10]   Cellular uptake of chloroquine is dependent on binding to ferriprotoporphyrin IX and is independent of NHE activity in Plasmodium falciparum [J].
Bray, PG ;
Janneh, O ;
Raynes, KJ ;
Mungthin, M ;
Ginsburg, H ;
Ward, SA .
JOURNAL OF CELL BIOLOGY, 1999, 145 (02) :363-376